Loan Instruments — Atlas of Innovation

Definition

A loan instrument is a financial mechanism that reduces the cost of borrowing for companies or projects. A public funder can act in several ways: providing loans directly, subsidizing interest rates on private loans, offering flexible repayment terms, or guaranteeing full or partial repayment to lenders in the event of borrower default.

Alongside R&D contracts, loan instruments are an appealing choice for push funding to commercial ventures. However, loan instruments are often overprescribed as a solution to address financing challenges that well-functioning capital markets already handle effectively.

Why might loan instruments be the right funding approach?

Loan instruments work best when there is a capable private-sector team that is well-positioned to commercialize a solution and generate near-term returns. Loan instruments require repayment, creating financial discipline and ensuring companies have strong incentives for performance. This selects for firms pursuing commercially viable projects with the potential to generate financial returns sufficient to repay the loan.

Successful uses of loan instruments let governments leverage relatively small budget outlays by recouping a large portion of funds — or by catalyzing far larger private investments in innovation. Government or philanthropic funders may partner with private lenders to finance projects. Private funders bring expertise and strong financial incentives to screen projects for commercial viability.

Loan instruments are most effective when the following conditions are present:

Identifiable teams: To administer contracts, the funder needs to confidently identify or competitively select the team best placed to pursue the innovation. This works best in fields where prior work, expertise, or submitted information provides a strong signal of competence.
Unique, private sector expertise: Private sector actors sometimes develop specialized technical capabilities ahead of academic or public institutions, positioning them to execute work on a given innovation area more effectively.
Revenue-generating potential: Projects must have plausible near-term pathways to profitability in order to generate sufficient returns for loan repayment.

Loan instruments offer important advantages over other funding approaches:

Encouraging financial discipline: Unlike grants, loans place repayment obligations on recipients, creating more built-in accountability that encourages discipline and efficient operations.
Leveraging private lender expertise: When sharing risk with private lenders, loan instruments incentivize private lenders to apply their screening expertise to evaluate project viability, improving selection quality where private lenders have expertise.
Amplifying government investment: Relative to other funding approaches, such as research grants, loan instruments generally involve more significant partnerships with private sector investors. This provides the opportunity to crowd-in private sector investment and, thus, supports larger investment volumes with the same public budget. Well-executed public loan instruments often break even or generate a return, but taxpayers still bear the risk of incurring real costs through defaults, interest rate subsidies, and administrative expenses.
Overcoming timeline mismatches: While capital markets are generally effective at evaluating risk, they are not incentivized to invest in projects that generate delayed social benefits with small profits. Investing in solutions to major social problems early can yield significant benefits but requires investment timelines that exceed what standard banking and venture capital structures are designed to support. Loan subsidies mitigate this mismatch by providing longer-term, more patient financing.

Ways to offer loan instruments

Funders can choose among several types of loan instruments, each with varying levels of direct cost, private-sector involvement, and risk of introducing perverse incentives:

Direct loan provisions: The funder provides loans directly to borrowers, often at below-market interest rates. Direct loans maximize funder control over terms but require the largest direct capital expenditures and risk crowding out private lenders. Direct loan provisions can generate net positive returns for the funder. For example, the Department of Energy’s Advanced Technology Vehicles Manufacturing Loan Program provided a $2.5 billion loan to Ultium Cells, a lithium-ion battery cell manufacturing venture.

Interest rate subsidies: A subsidy lowers the effective interest rate for borrowers. This approach leverages private-sector expertise but imposes ongoing fiscal costs to the funder, since there is no repayment stream. For example, Gujarat’s Scheme for Assistance for Startups/Innovation provides interest rate subsidies on loans to qualifying startups.

Flexible repayment terms: Borrowers receive more manageable repayment options, such as income-based repayment, deferred payments, or extended schedules. While effective at targeting relief, these instruments shift repayment risk onto the funder’s balance sheet and can encourage moral hazard (i.e., the borrower may take on additional risk because they know the funder will back them). For example, the United Kingdom’s innovation funding body, UK Research and Innovation, offers late-stage research and development loans that provide loan extension periods for projects focused on several innovation focus areas including health and artificial intelligence.

Loan guarantees: The funder promises to cover full or partial repayment if the borrower defaults on a loan. For example, the Asian Development Bank provides loan guarantees to protect against political risks.

What can go wrong?

Loan instruments are powerful tools for stimulating innovation, but poor design or implementation can undermine their effectiveness. Common challenges include:

Poor project underwriting: Programs may overestimate or underestimate the default risk of specific companies and projects, leading to backing companies that ultimately fail or leaving worthy companies with overly conservative terms. More broadly, instruments risk underwriting losing companies or investing in sectors that aren’t viable for large-scale success. Political pressure, such as pressure to support specific companies or only support safe options, can further distort these selection decisions.
Limited effectiveness in well-functioning markets: Loan instruments provide little value in sectors where capital markets already function well, potentially wasting resources where social benefits are minimal. Policymakers may incorrectly assume that the private sector has overstated risk and, subsequently, invest in a market that does not benefit from public sector financing. In these cases, loan instruments may crowd out private capital in the market and shift costs onto taxpayers without addressing real market failures.
High administrative complexity: Implementing loan instruments requires robust program administration, including loan assessment, ongoing monitoring, and counterparty management. Complexities increase when dealing with innovative projects in niche sectors, as agencies must balance financial expertise with technical domain knowledge.

To mitigate these challenges, programs should target loan instruments to projects with demonstrated technical credibility and clear public value, establish transparent risk evaluation frameworks, include mechanisms to recover funds or liquidate collateral, and regularly review portfolio performance. However, these safeguards can increase administrative costs and create regulatory complexity that may discourage participation.

Examples

Governments, foundations, and mission-driven lenders use loan instruments to advance their innovation goals, both in the US and internationally:

U.S. Department of Energy’s Loan Programs Office: The DOE LPO guarantees loans to energy projects such as solar, energy storage, and electricity transmission infrastructure. It offers full or partial repayment of loans (i.e., guarantees) to companies and non-federal lenders. DOE loan guarantees vet investments for technical and commercial viability. The projects they invest in must raise additional financing from private lenders, which imposes financial discipline. One of its most prominent successes was its $465 million guaranteed loan to Tesla in 2010. Tesla not only repaid the loan nine years early but also became one of the world’s largest electric vehicle manufacturers, setting industry benchmarks and helping to create a global market for electric vehicles.
World Bank Group: The World Bank Group provides various forms of loan instruments, including below-interest-rate loans and loan guarantees, to support projects in low- and middle-income countries. Through its various arms, private sector companies, financial institutions, and governments receive loans from the World Bank Group across multiple investment areas, including agriculture, energy, transportation, and infrastructure. Innovation in these fields often must be tailored to specific geographies.

In agriculture, for example, the World Bank Group’s International Finance Corporation supported Twiga Foods, which developed a digital platform linking smallholder farmers to urban retailers, and Mahayco, a crop science company focused on crop breeding in India and Africa. Many of the World Bank Group’s loan instruments are arranged in partnership with private lenders, which encourages financial discipline and ensures that financing is directed to projects with both technical and commercial viability.

By layering loan instruments with other approaches, funders can align capital flows across the innovation lifecycle while efficiently managing risk allocation. Funders can use loan instruments alongside other approaches, including:

R&D contracts: R&D contracts and loan instruments are both ways to provide early capital (e.g., upfront or cost-reimbursable) to private sector researchers. Loan instruments have revenue-generating potential, whereas R&D contracts do not provide any opportunity for the funder to recoup funding.
Advance market commitments (AMCs): Where AMCs create market demand certainty, loan instruments provide the capital needed for producers to scale manufacturing or deliver products to market.
Milestone payments: For multi-stage projects funded through milestone payments, loan instruments can provide companies with the liquidity needed to pursue a milestone.
Research grants: While research grants de-risk early-stage research, loan instruments can support the later scaling phases, bridging the gap between proof of concept and commercialization. Because some loan instruments can generate returns for the government, loans can be more politically tractable than grants for companies.

Definition

Why might loan instruments be the right funding approach?

What can go wrong?

Examples

Related funding approaches

Further reading